Tore Bach-Gansmo


    Publications 2023

    Bach-Gansmo T, Hodt A, Schjesvold FH, Gude E, Wien TN (2023)
    Bone scintigraphy reduces the need for biopsy in suspected cardiac amyloidosis
    Tidsskr Nor Laegeforen, 143 (9)
    DOI 10.4045/tidsskr.22.0644, PubMed 37341415

    Bogsrud T, Jacobsen M, Durski J, Larsen E, Engelsen O, Haskjold OI, Castillejo M, Bach-Gansmo T, Nostrand DV (2023)
    Letter to the Editor: Repeat Redifferentiation of Radioiodine Refractory BRAFV600E Mutated Thyroid Cancer with Dabrafenib
    Thyroid, 33 (6), 771-773
    DOI 10.1089/thy.2022.0651, PubMed 37212326

    Publications 2022

    Bach-Gansmo T, Korsan K, Bogsrud TV (2022)
    Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
    Tomography, 8 (3), 1477-1484
    DOI 10.3390/tomography8030120, PubMed 35736868

    Hoareau R, Bach-Gansmo T, Cumming P, Olberg DE (2022)
    A new automated and putatively versatile synthesis of the PSMA-ligand derivative [18F]DCFPyL using the FASTlabTM synthesizer
    EJNMMI Radiopharm Chem, 7 (1), 10
    DOI 10.1186/s41181-022-00157-0, PubMed 35507241

    Lindemann M, Oteiza A, Martin-Armas M, Guttormsen Y, Moldes-Anaya A, Berzaghi R, Bogsrud TV, Bach-Gansmo T, Sundset R, Kranz M (2022)
    Glioblastoma PET/MRI: kinetic investigation of [18F]rhPSMA-7.3, [18F]FET and [18F]fluciclovine in an orthotopic mouse model of cancer
    Eur J Nucl Med Mol Imaging, 50 (4), 1183-1194
    DOI 10.1007/s00259-022-06040-z, PubMed 36416908

    Publications 2019

    Bogsrud TV, Londalen A, Brandal P, Leske H, Panagopoulos I, Borghammer P, Bach-Gansmo T (2019)
    18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma
    Clin Nucl Med, 44 (8), 605-611
    DOI 10.1097/RLU.0000000000002641, PubMed 31274605

    Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Fendler WP, Czernin J (2019)
    What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply
    Lancet Oncol, 20 (11), e609-e610
    DOI 10.1016/S1470-2045(19)30654-0, PubMed 31674314

    Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J (2019)
    18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
    Lancet Oncol, 20 (9), 1286-1294
    DOI 10.1016/S1470-2045(19)30415-2, PubMed 31375469

    Nanni C, Zanoni L, Bach-Gansmo T, Minn H, Willoch F, Bogsrud TV, Edward EP, Savir-Baruch B, Teoh E, Ingram F, Fanti S, Schuster DM (2019)
    [18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0
    Eur J Nucl Med Mol Imaging, 47 (3), 579-591
    DOI 10.1007/s00259-019-04614-y, PubMed 31822959

    Publications 2017

    Blakkisrud J, Holtedahl JE, Løndalen A, Dahle J, Bach-Gansmo T, Holte H, Nygaard S, Kolstad A, Stokke C (2017)
    Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
    J Nucl Med, 59 (4), 704-710
    DOI 10.2967/jnumed.117.195347, PubMed 28848035

    Publications 2016

    Bach-Gansmo T, Nanni C, Nieh PT, Zanoni L, Bogsrud TV, Sletten H, Korsan KA, Kieboom J, Tade FI, Odewole O, Chau A, Ward P, Goodman MM, Fanti S, Schuster DM, Willoch F (2016)
    Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer
    J Urol, 197 (3 Pt 1), 676-683
    DOI 10.1016/j.juro.2016.09.117, PubMed 27746282

    Blakkisrud J, Løndalen A, Martinsen AC, Dahle J, Holtedahl JE, Bach-Gansmo T, Holte H, Kolstad A, Stokke C (2016)
    Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
    J Nucl Med, 58 (1), 48-54
    DOI 10.2967/jnumed.116.173922, PubMed 27493270

    Munthe E, Riss PJ, Saga TA, Haraldsen I, Grad I, Bogsrud TV, Bach-Gansmo T (2016)
    FDG-based quantitative comparison of glucose metabolism in vitro, exemplified by a head-to-head comparison between a triple-negative breast cancer cell line and a non-malignant foetal cell line
    Clin Physiol Funct Imaging, 38 (1), 34-37
    DOI 10.1111/cpf.12378, PubMed 27297457

    Publications 2015

    Schulz A, Godt JC, Dormagen JB, Holtedahl JE, Bogsrud TV, Labori KJ, Kløw NE, Bach-Gansmo T (2015)
    Respiratory gated PET/CT of the liver: A novel method and its impact on the detection of colorectal liver metastases
    Eur J Radiol, 84 (8), 1424-1431
    DOI 10.1016/j.ejrad.2015.05.011, PubMed 26044293

    Schulz A, Viktil E, Godt JC, Johansen CK, Dormagen JB, Holtedahl JE, Labori KJ, Bach-Gansmo T, Kløw NE (2015)
    Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI
    Acta Radiol, 57 (9), 1040-8
    DOI 10.1177/0284185115617349, PubMed 26622057

    Publications 2014

    Bach-Gansmo T, Wien TN, Løndalen A, Halvorsen E (2014)
    Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake
    Clin Physiol Funct Imaging, 36 (3), 237-41
    DOI 10.1111/cpf.12219, PubMed 25524030

    Schuster DM, Nanni C, Fanti S, Oka S, Okudaira H, Inoue Y, Sörensen J, Owenius R, Choyke P, Turkbey B, Bogsrud TV, Bach-Gansmo T, Halkar RK, Nye JA, Odewole OA, Savir-Baruch B, Goodman MM (2014)
    Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease
    J Nucl Med, 55 (12), 1986-92
    DOI 10.2967/jnumed.114.143628, PubMed 25453047

    Publications 2013

    Babovic A, Müller C, Bach-Gansmo T (2013)
    [When should thyroid scintigraphy be performed?]
    Tidsskr Nor Laegeforen, 133 (9), 937
    DOI 10.4045/tidsskr.13.0298, PubMed 23652138

    Johnsrud K, Skretting A, Naum AG, Bogsrud TV, Bach-Gansmo T (2013)
    Characterization of an asymmetric add-on collimator used with a hand-held gamma probe for radioguided surgery and sentinel node detection: a demonstration of an alternative collimation method
    Clin Physiol Funct Imaging, 33 (6), 478-82
    DOI 10.1111/cpf.12057, PubMed 23758686

    Publications 2012

    Bach-Gansmo T, Dybvik J, Adamsen T, Naum A (2012)
    Variation in urinary excretion of FDG, yet another uncertainty in quantitative PET
    Acta Radiol Short Rep, 1 (8)
    DOI 10.1258/arsr.2012.120038, PubMed 23986849

    Publications 2011

    Bach-Gansmo T, Bogsrud TV, Holmboe L, Pedersen EL, Müller C (2011)
    Extraosseous uptake with DPD (Teceos(®))
    Clin Physiol Funct Imaging, 31 (5), 358-62
    DOI 10.1111/j.1475-097X.2011.01024.x, PubMed 21771254

    Revheim ME, Røe K, Bruland ØS, Bach-Gansmo T, Skretting A, Seierstad T (2011)
    Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
    Mol Imaging Biol, 13 (6), 1234-40
    DOI 10.1007/s11307-010-0464-0, PubMed 21161686

    Publications 2010

    Axelsson R, Bach-Gansmo T, Castell-Conesa J, McParland BJ, Study Group (2010)
    An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692
    Acta Radiol, 51 (1), 40-6
    DOI 10.3109/02841850903273974, PubMed 20001475

    Bach-Gansmo T, Schwarzlmüller T, Jøraholmen V, Salbu J, Biermann M, Naum A, Kleven-Madsen N (2010)
    SPECT/CT hybrid imaging; with which CT?
    Contrast Media Mol Imaging, 5 (4), 208-12
    DOI 10.1002/cmmi.375, PubMed 20812288

    Publications 2009

    Bach-Gansmo T, Bogsrud TV (2009)
    [Assessment of new medical technology]
    Tidsskr Nor Laegeforen, 129 (7), 646
    DOI 10.4045/tidsskr.09.33526, PubMed 19337338

    Biermann M, Johnsen B, Sørbye H, Følling M, Sundin A, Bach-Gansmo T (2009)
    [Positron emission tomography in neuroendocrine tumours]
    Tidsskr Nor Laegeforen, 129 (15), 1474-7
    DOI 10.4045/tidsskr.08.0068, PubMed 19690598

    Revheim ME, Seierstad T, Berner JM, Bruland OS, Røe K, Ohnstad HO, Bjerkehagen B, Bach-Gansmo T (2009)
    Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice
    Anticancer Res, 29 (11), 4331-6
    PubMed 20032375

    Publications 2008

    Bach-Gansmo T, Bogsrud TV, Skretting A (2008)
    Integrin scintimammography using a dedicated breast imaging, solid-state gamma-camera and (99m)Tc-labelled NC100692
    Clin Physiol Funct Imaging, 28 (4), 235-9
    DOI 10.1111/j.1475-097X.2008.00801.x, PubMed 18384623

    Publications 2006

    Bach-Gansmo T, Danielsson R, Saracco A, Wilczek B, Bogsrud TV, Fangberget A, Tangerud A, Tobin D (2006)
    Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692
    J Nucl Med, 47 (9), 1434-9
    PubMed 16954550

    Holte O, Skretting A, Bach-Gansmo T, Hol PK, Johnsrud K, Tønnesen HH, Karlsen J (2006)
    Localized internal radiotherapy with 90Y particles embedded in a new thermosetting alginate gel: a feasibility study in pigs
    Nucl Med Commun, 27 (2), 185-90
    DOI 10.1097/01.mnm.0000194398.97195.d9, PubMed 16404233

    Publications 2004

    Bach-Gansmo T, Bogsrud TV, Aas M, Jørgensen LH, Fischer BM (2004)
    [Positron emission tomography in the diagnosis of lung cancer]
    Tidsskr Nor Laegeforen, 124 (8), 1088-9
    PubMed 15114384

    Publications 2002

    Bach-Gansmo T, Bogsrud TV (2002)
    [Lung cancer]
    Tidsskr Nor Laegeforen, 122 (26), 2559-60; author reply 2560
    PubMed 12522888

    Publications 2001

    Dupas B, Buzelin MF, Karam G, Vasse N, Meflah K, Bach-Gansmo T (2001)
    Contrast-enhanced MR imaging of experimental acute tubular necrosis
    Acta Radiol, 42 (1), 74-9
    DOI 10.1080/028418501127346279, PubMed 11167336

    Dupas B, Pradal G, Muller RN, Bonnemain B, Meflah K, Bach-Gansmo T (2001)
    Hepatocyte-mediated transport to the bile of AMI-HS, a particulate contrast agent
    Invest Radiol, 36 (9), 509-17
    DOI 10.1097/00004424-200109000-00002, PubMed 11547038

    Publications 1999

    Dupas B, Bach-Gansmo T, Blancho G, Franconi JM, Havet T, Léauté F (1999)
    Gadolinium-enhanced MR imaging of normal renal transplants. An evaluation of a T1-weighted dynamic echo-planar sequence
    Acta Radiol, 40 (3), 250-4
    DOI 10.3109/02841859909175550, PubMed 10335961

    Publications 1998

    Dupas B, Bach-Gansmo T, Meflah K, Muller RN (1998)
    Synergistic effects of relaxation and susceptibility in differentiation between compartmentalized and noncompartmentalized tissues
    Invest Radiol, 33 (5), 268-72
    DOI 10.1097/00004424-199805000-00003, PubMed 9609485

    Publications 1997

    Dupas B, Bach-Gansmo T, Nomballais MF, Meflah K (1997)
    Delineation of liver necrosis using double contrast-enhanced MRI
    J Magn Reson Imaging, 7 (3), 472-7
    DOI 10.1002/jmri.1880070304, PubMed 9170029

    Wang C, Sundin A, Ericsson A, Bach-Gansmo T, Hemmingsson A, Ahlström H (1997)
    Dysprosium-enhanced MR imaging for tumor tissue characterization. An experimental study in a human xenograft model
    Acta Radiol, 38 (2), 281-6
    DOI 10.1080/02841859709172064, PubMed 9093166

    Publications 1996

    Bach-Gansmo T (1996)
    Professional confidentiality is a major right to which our patients are entitled
    Acta Radiol, 37 (1), 121
    DOI 10.1177/02841851960371P123, PubMed 8611315

    Publications 1995

    Ericsson A, Bach-Gansmo T, Niklasson F, Hemmingsson A (1995)
    Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging
    Acta Radiol, 36 (1), 41-6
    PubMed 7833167

    Publications 1994

    Bach-Gansmo T, Fahlvik AK, Ericsson A, Hemmingsson A (1994)
    Superparamagnetic iron oxide for liver imaging. Comparison among three different preparations
    Invest Radiol, 29 (3), 339-44
    DOI 10.1097/00004424-199403000-00014, PubMed 8175309

    Wallengren NO, Holtås S, Andrén-Sandberg A, Bach-Gansmo T (1994)
    MR imaging of the pancreas at 0.3 T using a super-paramagnetic oral contrast medium
    Acta Radiol, 35 (2), 147-51
    PubMed 8172740

    Publications 1993

    Bach-Gansmo T (1993)
    Ferrimagnetic susceptibility contrast agents
    Acta Radiol Suppl, 387, 1-30
    PubMed 8390776

    Bach-Gansmo T (1993)
    Ferrimagnetic susceptibility contrast agents
    Munksgaard, Copenhagen, 30 s.
    BIBSYS 942142284, ISBN 91-628-0871-0

    Bach-Gansmo T, Dupas B, Gayet-Delacroix M, Lambrechts M (1993)
    Abdominal MRI using a negative contrast agent
    Br J Radiol, 66 (785), 420-5
    DOI 10.1259/0007-1285-66-785-420, PubMed 8319063

    Boudghène FP, Bach-Gansmo T, Grange JD, Lame S, Nantois C, Wallays C, Bigot JM (1993)
    Contribution of oral magnetic particles in MR imaging of the abdomen with spin-echo and gradient-echo sequences
    J Magn Reson Imaging, 3 (1), 107-12
    DOI 10.1002/jmri.1880030118, PubMed 8428075

    Oksendal AN, Bach-Gansmo T, Jacobsen TF, Eide H, Andrew E (1993)
    Oral magnetic particles. Results from clinical phase II trials in 216 patients
    Acta Radiol, 34 (2), 187-93
    PubMed 8452728

    Publications 1992

    Bach-Gansmo T, Ericsson A, Leander P, Fahlvik AK, Hemmingsson A (1992)
    Motion associated susceptibility artifacts
    Acta Radiol, 33 (6), 606-10
    PubMed 1449890

    Publications 1991

    Ericsson A, Lönnemark M, Hemmingsson A, Bach-Gansmo T (1991)
    Effect of superparamagnetic particles in agarose gels. A magnetic resonance imaging study
    Acta Radiol, 32 (1), 74-8
    PubMed 2012737

    Lönnemark M, Hemmingsson A, Bach-Gansmo T, Hagberg H, Magnusson A, Gundersen HG, Nyman R (1991)
    Superparamagnetic particles as oral contrast medium in MR imaging of malignant lymphoma
    Acta Radiol, 32 (3), 232-8
    DOI 10.1177/028418519103200309, PubMed 2064867

    Publications 1990

    Gundersen HG, Bach-Gansmo T, Holtz E, Fahlvik AK, Berg A (1990)
    Superparamagnetic contrast agents for magnetic resonance imaging
    Invest Radiol, 25 Suppl 1, S67-8
    DOI 10.1097/00004424-199009001-00032, PubMed 2283261

    Holtås S, Wallengren NO, Ericsson A, Bach-Gansmo T (1990)
    Signal alterations, artifacts and image distortion induced by a superparamagnetic contrast medium. A phantom study in a 0.3 tesla MR system
    Acta Radiol, 31 (2), 213-6
    PubMed 2372467

    Lönnemark M, Hemmingsson A, Ericsson A, Gundersen HG, Bach-Gansmo T (1990)
    Oral superparamagnetic particles for magnetic resonance imaging. Effect in plain and viscous aqueous suspensions
    Acta Radiol, 31 (3), 303-7
    DOI 10.3109/02841859009171997, PubMed 2386643

    Niemi P, Katevuo K, Kormano M, Baksaas I, Bach-Gansmo T, Mäenpää J (1990)
    Superparamagnetic particles as gastrointestinal contrast agent in magnetic resonance imaging of lower abdomen
    Acta Radiol, 31 (4), 409-11
    PubMed 2206698

    Publications 1989

    Lönnemark M, Hemmingsson A, Bach-Gansmo T, Ericsson A, Oksendal A, Nyman R, Moxnes A (1989)
    Effect of superparamagnetic particles as oral contrast medium at magnetic resonance imaging. A phase I clinical study
    Acta Radiol, 30 (2), 193-6
    DOI 10.1177/028418518903000215, PubMed 2923745

    Publications 1988

    Andrew E, Waaler A, Jakobsen J, Holager T, Lambrechts M, Moxnes A, Kruger Hagen E, Bach-Gansmo T (1988)
    Clinical trial program for iopentol. A new nonionic ratio 3.0 contrast medium with emphasis on clinical phases I and II
    Invest Radiol, 23 Suppl 1, S189-92
    DOI 10.1097/00004424-198809001-00034, PubMed 3058629

    Maly P, Bach-Gansmo T, Elmqvist D (1988)
    Risk of seizures after myelography: comparison of iohexol and metrizamide
    AJNR Am J Neuroradiol, 9 (5), 879-83
    PubMed 3140631

    Publications 1987

    Bach-Gansmo T (1987)
    [Contrast media for magnetic resonance tomography]
    Tidsskr Nor Laegeforen, 107 (1), 33-6
    PubMed 3824287

    Valk J, Crezée FC, de Slegte RG, Hazenberg GJ, Wolbers J, Bach-Gansmo T (1987)
    Iohexol 300 mg I/ml versus Iopamidol 300 mg I/ml for cervical myelography double blind trial
    Neuroradiology, 29 (2), 202-5
    DOI 10.1007/BF00327551, PubMed 3295584

    Publications 1986

    Lilleås F, Bach-Gansmo T, Weber H (1986)
    Lumbar myelography with Omnipaque (iohexol)
    Neuroradiology, 28 (4), 344-6
    DOI 10.1007/BF00333442, PubMed 3762913

    Publications 1985

    Shaw DD, Bach-Gansmo T, Dahlstrom K (1985)
    Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium
    Invest Radiol, 20 (1 Suppl), S44-50
    DOI 10.1097/00004424-198501002-00011, PubMed 3882616

    Publications 1984

    Nakstad P, Aaserud O, Helgetveit A, Nyberg-Hansen R, Ganes T, Bach-Gansmo T (1984)
    Cervical myelography with iohexol
    Neuroradiology, 26 (2), 123-9
    DOI 10.1007/BF00339860, PubMed 6717790

    Page visits: 6876